THC Biomed Intl Ltd. (THCBF)
PNK: THCBF
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: May 22, 2025, 8:00 PM
THC Biomed Intl Statistics
Share Statistics
THC Biomed Intl has 2,354.9B shares outstanding. The number of shares has increased by 296375.94% in one year.
| Shares Outstanding | 2,354.9B |
| Shares Change (YoY) | 296375.94% |
| Shares Change (QoQ) | 0.66% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,605 |
| FTD / Avg. Volume | 13.6% |
Short Selling Information
The latest short interest is 1.37K, so 0% of the outstanding shares have been sold short.
| Short Interest | 1.37K |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | 340.7 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
THC Biomed Intl has an Enterprise Value (EV) of 5.26M.
| EV / Sales | 0 |
| EV / EBITDA | 0 |
| EV / EBIT | 0 |
| EV / FCF | 0 |
Financial Position
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 0% and Return on Invested Capital is 0%.
| Return on Equity | 0% |
| Return on Assets | 0% |
| Return on Invested Capital | 0% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 35 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.1, so THC Biomed Intl's price volatility has been higher than the market average.
| Beta | 0.1 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 51.53 |
| Average Volume (20 Days) | 11,799 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Net Income | n/a |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | n/a |
| Total Assets | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
THCBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 0% |
| FCF Yield | 0% |
Analyst Forecast
Currently there are no analyst rating for THCBF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |